Research programme: cardiology diagnostics - BTG

Drug Profile

Research programme: cardiology diagnostics - BTG

Alternative Names: BGC-C2I molecular imaging probe; Cardiology diagnostics research programme - BTG

Latest Information Update: 07 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator BTG
  • Class Radiopharmaceutical diagnostics
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Coronary artery disease

Most Recent Events

  • 07 May 2007 No development reported - Preclinical for Coronary artery disease (diagnosis) in USA (unspecified route)
  • 01 Mar 2004 The programme is available for licensing in in Europe and North America (http://www.btgplc.com)
  • 01 Mar 2004 Preclinical trials in Coronary artery disease (diagnosis) in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top